← Back to Clinical Trials
Recruiting NCT07600242

NCT07600242 Word Learning in Bilingual Typical and Late Talking Children: The Role of Meaning and Input

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07600242
Status Recruiting
Phase
Sponsor Boston University Charles River Campus
Condition Bilingualism
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-12-16
Primary Completion 2028-07-31

Eligibility & Interventions

Sex All sexes
Min Age 24 Months
Max Age 30 Months
Study Type INTERVENTIONAL
Interventions
Large Semantic Category ConditionSmall Semantic Category Condition

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-12-16 with a primary completion date of 2028-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to understand how different types of word categories, along with the language children hear from their parents, support bilingual toddlers' word learning. This study will address two main questions: (1) How are the words toddlers know related to the words their parents use? and (2) How does what toddlers already know help them learn new words in two languages? The investigators will compare bilingual toddlers with typical development to those with language delay to determine whether they learn new words in similar ways. Children's vocabulary knowledge will be assessed using standardized parent-report checklists. To examine how different types of categories support learning, the study will focus on two early-acquired categories: animals and clothing. The investigators will compare what parents report about their children's vocabulary with how children learn new words within each category. To understand the role of parent input, children and their parents will engage in shared book reading and play activities using materials from one of the target categories. Parent-child interactions will be video recorded. Children will also complete an eye-tracking task in which they learn new words in two languages within the same category.

Eligibility Criteria

Inclusion Criteria: * At least 10% exposure to both English and Spanish or at least 90% exposure to English and another language Exclusion Criteria: * Hearing impairment * Uncorrected visual impairment * Neurological impairment * Genetic syndromes * Neurodevelopmental disabilities (e.g. autism) * More than 10% exposure to a language other than English or Spanish

Frequently Asked Questions

Who can join the NCT07600242 clinical trial?

This trial is open to participants of all sexes, aged 24 Months or older, up to 30 Months, studying Bilingualism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07600242 currently recruiting?

Yes, NCT07600242 is actively recruiting participants. Visit ClinicalTrials.gov or contact Boston University Charles River Campus to inquire about joining.

Where is the NCT07600242 trial being conducted?

This trial is being conducted at Boston, United States.

Who is sponsoring the NCT07600242 clinical trial?

NCT07600242 is sponsored by Boston University Charles River Campus. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology